维普期刊资源整合服务平台（V6.5）

167篇 您的检索式：作者名="Craig WA"

选中清除导出查看参考文献查看引证文献引用追踪共9页首页上一页第1页下一页末页 /9 跳转

	题名	作者	年代	出处	被引量
1	Quantitation of mecA transcription in oxacillin-resistant Staphylococcus aureus clinical isolates显示文摘	Rosato AE Craig WA Archer GL	2003	J Bacteriol2003，185，11：	1
2	Pharmacokinetic/phannacodynamic parameters :rationale for antibacterial dosing of mice and men 显示文摘	Craig WA	1998	Clin Infect Dis1998，26，：	1
3	Outcomes evaluation of patients with ESBLs-and non-ESBLs-producing Escherichia coli and Klebsiella species as defined by CLSI reference methods: report from the SENTRY Antimicrobial Surveillance Program显示文摘	Bhavnani SM Ambrose PG Craig WA	2006	Diagn Microbiol Infect Dis2006，54，3：	1
4	Treatment of infections with ESBL-producing organisms: pharmacokinetic and pharmacodynamic considerations 显示文摘	Andes D Craig WA	2005	Clin Microbial Infect2005，6，：	1
5	Pharmaeodynamics of antimicrobial agents as a basis for detemli- ning dosage regimens显示文摘	Craig WA	1993	Clin Microbial infect Dis1993，12，：	1
6	Evidence to support the rationale that bacterial eradication in respiratory tract infection is an important aim of antimicrobial therapy 显示文摘	Dagan R Klugman KP Craig WA	2001	J Antimicrob Chemother2001，47，2：	1
7	Interralationship between pharmacokinetics and phannaeodynamics in detenning dosage reginmins for hroad-specman eephalosporins 显示文摘	Craig WA	1995	Diagn Microbol Infection Dis1995，22，5：	1
8	Antimicrobial resistant issues of the future显示文摘	Craig WA	1996	Diagn Microbial Infect Dis1996，25，：	1
9	Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid 显示文摘	Craig WA	2003	Infect Dis Clin North Am2003，17，3：	1
10	Antimicrobial resistance issues of the future显示文摘	Craig WA	1996	Diagn Microbiol Infect Dis1996，25，：	1
11	Have we reached the point of no return? The hidden impact of antibacterial resistance in respiratory tract infect显示文摘	Craig WA	2001	Respir Med2001，95，：	1
12	Relevance of pharmacokinetics and pharmaco-dynamics in the selection of antibiotics for respiratory tract infections显示文摘	Drusano GL Craig WA	1997	J Chemother1997，9，：	1
13	Pharmacokinetic/pharmacodynamic parameters:rational for antibacterial dosing of mice and men显示文摘	Craig WA	1998	Clin Infec Dis1998，26，：	1
14	Pharmacokinetic/pharmacodynamic indices:rationale for antibacterial dosing of mice and men显示文摘	Craig WA	1998	Clin Infect Dis1998，26，：	1
15	Choosing an antibiotic on the basis of pharmacodynamics显示文摘	Craig WA	1998	Ear Nose Throat J1998，77，：	1
16	In vivo activities of amoxicillin and amoxicillin-clavulanate against Streptococcus pneumoniae:application to breakpoint determinations显示文摘	Andes D Craig WA	1998	Antimicrob Agents Chemother1998，42，：	1
17	Tigecycline: a critical analysis显示文摘	Stein GE Craig WA	2006	Clin Infent Dis2006，43，4：	1
18	Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad spectrum cephlosporins显示文摘	Craig WA	1995	Diagn Microbiol Infect Dis1995，22，：	1
19	Pharmacokinetic/pharmacodynamic parameters:rationale for antibacterial dosing of mice and men显示文摘	Craig WA	1998	Clin Infect Dis1998，26，1：	1
20	Tigecycline: a critical analysis 显示文摘	Stein GE Craig WA	2006	Clin Infect Dis2006，43，4：	1

返回顶部每页显示：

共9页首页上一页第1页下一页末页 /9 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示